位置:首页 > 蛋白库 > CLASR_HUMAN
CLASR_HUMAN
ID   CLASR_HUMAN             Reviewed;         674 AA.
AC   Q8N2M8; B4DDT8; F8WAG9; O96026; Q6UW71; Q96DX2;
DT   19-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   14-APR-2009, sequence version 4.
DT   03-AUG-2022, entry version 157.
DE   RecName: Full=CLK4-associating serine/arginine rich protein;
DE   AltName: Full=Splicing factor, arginine/serine-rich 16;
DE   AltName: Full=Suppressor of white-apricot homolog 2;
GN   Name=CLASRP; Synonyms=SFRS16, SWAP2; ORFNames=UNQ2428/PRO4988;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), AND VARIANT GLU-174.
RA   Yoshiura K., Murray J.C.;
RT   "A transcriptional map in the region of 19q13 derived using direct
RT   sequencing and exon trapping.";
RL   Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT GLU-174.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT GLU-174.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLU-174.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-547, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-285; THR-327; SER-331 AND
RP   SER-335, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-331 AND SER-335, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-547, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-285 AND SER-547, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-101; SER-285; SER-294;
RP   SER-547 AND THR-573, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-285 AND SER-547, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-213.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Probably functions as an alternative splicing regulator. May
CC       regulate the mRNA splicing of genes such as CLK1. May act by regulating
CC       members of the CLK kinase family (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Probably interacts with CLK4. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q8N2M8; Q9NU02: ANKEF1; NbExp=3; IntAct=EBI-751069, EBI-8464238;
CC       Q8N2M8; Q9Y6A4: CFAP20; NbExp=4; IntAct=EBI-751069, EBI-1046872;
CC       Q8N2M8; P49759-3: CLK1; NbExp=3; IntAct=EBI-751069, EBI-11981867;
CC       Q8N2M8; P49760: CLK2; NbExp=3; IntAct=EBI-751069, EBI-750020;
CC       Q8N2M8; P49761: CLK3; NbExp=4; IntAct=EBI-751069, EBI-745579;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8N2M8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N2M8-3; Sequence=VSP_013894, VSP_013895;
CC       Name=3;
CC         IsoId=Q8N2M8-4; Sequence=VSP_055717;
CC   -!- PTM: Phosphorylated in vitro by CLK4. {ECO:0000250}.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the splicing factor SR family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-16 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC82339.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAC82340.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH80554.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF042800; AAC82339.1; ALT_INIT; mRNA.
DR   EMBL; AF042810; AAC82340.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AF042802; AAC82340.1; JOINED; Genomic_DNA.
DR   EMBL; AF042803; AAC82340.1; JOINED; Genomic_DNA.
DR   EMBL; AF042804; AAC82340.1; JOINED; Genomic_DNA.
DR   EMBL; AF042805; AAC82340.1; JOINED; Genomic_DNA.
DR   EMBL; AF042806; AAC82340.1; JOINED; Genomic_DNA.
DR   EMBL; AF042807; AAC82340.1; JOINED; Genomic_DNA.
DR   EMBL; AF042808; AAC82340.1; JOINED; Genomic_DNA.
DR   EMBL; AF042809; AAC82340.1; JOINED; Genomic_DNA.
DR   EMBL; AY358944; AAQ89303.1; -; mRNA.
DR   EMBL; AK293333; BAG56849.1; -; mRNA.
DR   EMBL; AC011489; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC080554; AAH80554.1; ALT_INIT; mRNA.
DR   CCDS; CCDS12652.2; -. [Q8N2M8-1]
DR   CCDS; CCDS62710.1; -. [Q8N2M8-4]
DR   RefSeq; NP_001265368.1; NM_001278439.1.
DR   RefSeq; NP_008987.2; NM_007056.2.
DR   AlphaFoldDB; Q8N2M8; -.
DR   SMR; Q8N2M8; -.
DR   BioGRID; 116302; 81.
DR   IntAct; Q8N2M8; 32.
DR   STRING; 9606.ENSP00000221455; -.
DR   GlyGen; Q8N2M8; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q8N2M8; -.
DR   PhosphoSitePlus; Q8N2M8; -.
DR   BioMuta; CLASRP; -.
DR   DMDM; 226694202; -.
DR   EPD; Q8N2M8; -.
DR   jPOST; Q8N2M8; -.
DR   MassIVE; Q8N2M8; -.
DR   MaxQB; Q8N2M8; -.
DR   PaxDb; Q8N2M8; -.
DR   PeptideAtlas; Q8N2M8; -.
DR   PRIDE; Q8N2M8; -.
DR   ProteomicsDB; 30495; -.
DR   ProteomicsDB; 71717; -. [Q8N2M8-1]
DR   ProteomicsDB; 71718; -. [Q8N2M8-3]
DR   Antibodypedia; 54055; 73 antibodies from 19 providers.
DR   DNASU; 11129; -.
DR   Ensembl; ENST00000391952.7; ENSP00000375814.2; ENSG00000104859.15.
DR   Ensembl; ENST00000391953.8; ENSP00000375815.3; ENSG00000104859.15.
DR   GeneID; 11129; -.
DR   KEGG; hsa:11129; -.
DR   UCSC; uc010xxh.3; human. [Q8N2M8-1]
DR   CTD; 11129; -.
DR   DisGeNET; 11129; -.
DR   GeneCards; CLASRP; -.
DR   HGNC; HGNC:17731; CLASRP.
DR   HPA; ENSG00000104859; Low tissue specificity.
DR   MIM; 618532; gene.
DR   neXtProt; NX_Q8N2M8; -.
DR   PharmGKB; PA134961731; -.
DR   VEuPathDB; HostDB:ENSG00000104859; -.
DR   eggNOG; KOG2548; Eukaryota.
DR   InParanoid; Q8N2M8; -.
DR   OrthoDB; 1620115at2759; -.
DR   PhylomeDB; Q8N2M8; -.
DR   TreeFam; TF351621; -.
DR   PathwayCommons; Q8N2M8; -.
DR   SignaLink; Q8N2M8; -.
DR   BioGRID-ORCS; 11129; 364 hits in 1096 CRISPR screens.
DR   ChiTaRS; CLASRP; human.
DR   GeneWiki; SFRS16; -.
DR   GenomeRNAi; 11129; -.
DR   Pharos; Q8N2M8; Tbio.
DR   PRO; PR:Q8N2M8; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q8N2M8; protein.
DR   Bgee; ENSG00000104859; Expressed in adenohypophysis and 190 other tissues.
DR   ExpressionAtlas; Q8N2M8; baseline and differential.
DR   Genevisible; Q8N2M8; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   InterPro; IPR040397; SWAP.
DR   InterPro; IPR019147; SWAP_N_domain.
DR   PANTHER; PTHR13161; PTHR13161; 2.
DR   Pfam; PF09750; DRY_EERY; 1.
DR   SMART; SM01141; DRY_EERY; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; mRNA processing; mRNA splicing; Nucleus;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN           1..674
FT                   /note="CLK4-associating serine/arginine rich protein"
FT                   /id="PRO_0000081945"
FT   REGION          172..232
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          257..674
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          585..647
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        185..214
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        295..309
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        372..405
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        407..441
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        442..456
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        461..491
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        492..537
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        574..642
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         101
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         285
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         294
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         327
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         331
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         335
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         547
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         573
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         42..103
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055717"
FT   VAR_SEQ         570..594
FT                   /note="PKLTPQEKLKLRMQKALNRQFKADK -> VTQADASGEAETEDAEGAEQAVQ
FT                   GG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12975309"
FT                   /id="VSP_013894"
FT   VAR_SEQ         595..674
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12975309"
FT                   /id="VSP_013895"
FT   VARIANT         174
FT                   /note="K -> E (in dbSNP:rs4803794)"
FT                   /evidence="ECO:0000269|PubMed:12975309,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|Ref.1"
FT                   /id="VAR_016809"
FT   VARIANT         213
FT                   /note="L -> S (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035490"
SQ   SEQUENCE   674 AA;  77161 MW;  454F935EBDD96541 CRC64;
     MWHEARKHER KLRGMMVDYK KRAERRREYY EKIKKDPAQF LQVHGRACKV HLDSAVALAA
     ESPVNMMPWQ GDTNNMIDRF DVRAHLDHIP DYTPPLLTTI SPEQESDERK CNYERYRGLV
     QNDFAGISEE QCLYQIYIDE LYGGLQRPSE DEKKKLAEKK ASIGYTYEDS TVAKVEKAAE
     KPEEEESAAE EESNSDEDEV IPDIDVEVDV DELNQEQVAD LNKQATTYGM ADGDFVRMLR
     KDKEEAEAIK HAKALEEEKA MYSGRRSRRQ RREFREKRLR GRKISPPSYA RRDSPTYDPY
     KRSPSESSSE SRSRSRSPTP GREEKITFIT SFGGSDEEAA AAAAAAAASG VTTGKPPAPP
     QPGGPAPGRN ASARRRSSSS SSSSSASRTS SSRSSSRSSS RSRRGGGYYR SGRHARSRSR
     SWSRSRSRSR RYSRSRSRGR RHSGGGSRDG HRYSRSPARR GGYGPRRRSR SRSHSGDRYR
     RGGRGLRHHS SSRSRSSWSL SPSRSRSLTR SRSHSPSPSQ SRSRSRSRSQ SPSPSPAREK
     LTRPAASPAV GEKLKKTEPA AGKETGAAKP KLTPQEKLKL RMQKALNRQF KADKKAAQEK
     MIQQEHERQE REDELRAMAR KIRMKERERR EKEREEWERQ YSRQSRSPSP RYSREYSSSR
     RRSRSRSRSP HYRH
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024